Published in J Urol on November 13, 2007
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol (2010) 1.74
Tumour ablation: current role in the liver, kidney, lung and bone. Cancer Imaging (2008) 1.10
Tumour ablation: current role in the kidney, lung and bone. Cancer Imaging (2009) 0.90
Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy. World J Urol (2010) 0.90
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int (2013) 0.90
Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability. J Urol (2015) 0.88
Radiofrequency ablation of renal tumors: our experience. Korean J Urol (2011) 0.85
Perioperative and long-term renal functional outcomes of robotic versus laparoscopic partial nephrectomy: a multicenter matched-pair comparison. World J Urol (2015) 0.84
Review of the efficacy and safety of cryoablation for the treatment of small renal masses. Can Urol Assoc J (2013) 0.83
Renal function following curative surgery for renal cell carcinoma: who is at risk for renal insufficiency? Korean J Urol (2013) 0.83
Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients. Korean J Radiol (2012) 0.83
Comparison of laparoscopic radiofrequency ablation and open partial nephrectomy in patients with a small renal mass. Korean J Urol (2013) 0.81
Image-guided percutaneous renal cryoablation for stage 1 renal cell carcinoma with high surgical risk. World J Surg Oncol (2015) 0.81
Multicenter experience with nonischemic multiport laparoscopic and laparoendoscopic single-site partial nephrectomy utilizing bipolar radiofrequency ablation coagulator. Diagn Ther Endosc (2011) 0.78
Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J (2009) 0.78
Percutaneous radiofrequency ablation of renal tumors: a single-center experience. Korean J Urol (2013) 0.77
Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma. World J Urol (2015) 0.77
Kidney function outcomes following thermal ablation of small renal masses. World J Nephrol (2016) 0.75
Does radiofrequency ablation preserve long-term renal function in patients with small renal masses? Nat Clin Pract Urol (2008) 0.75
Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): a systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.75
Chronic kidney disease and small renal tumors: What urologists should know? Indian J Urol (2009) 0.75
Image-guided percutaneous microwave ablation of small renal tumours: short- and mid-term outcomes. Quant Imaging Med Surg (2015) 0.75
Renal functional outcomes after surgery for renal cortical tumors. J Kidney Cancer VHL (2015) 0.75
Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol (2017) 0.75
Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation. World J Urol (2012) 0.75
Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Oncol Lett (2017) 0.75
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
How to build and interpret a nomogram for cancer prognosis. J Clin Oncol (2008) 4.24
Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence. Eur Urol (2008) 4.09
Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation. J Urol (2019) 3.20
Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol (2009) 2.76
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol (2011) 2.72
YouTube as source of prostate cancer information. Urology (2009) 2.50
Laparoendoscopic single-site surgery in urology: worldwide multi-institutional analysis of 1076 cases. Eur Urol (2011) 2.46
Patient-reported body image and cosmesis outcomes following kidney surgery: comparison of laparoendoscopic single-site, laparoscopic, and open surgery. Eur Urol (2011) 2.34
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology (2007) 2.28
The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. J Urol (2004) 2.23
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur Urol (2008) 2.20
Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer. Nat Commun (2013) 2.11
Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol (2008) 2.03
The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol (2004) 1.97
Perioperative outcomes in patients undergoing conventional laparoscopic versus laparoendoscopic single-site pyeloplasty. Urology (2009) 1.96
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci Transl Med (2012) 1.84
Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol (2011) 1.83
Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol (2004) 1.81
Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol (2012) 1.78
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res (2012) 1.78
Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. Eur Urol (2013) 1.67
Current status and future directions of robotic single-site surgery: a systematic review. Eur Urol (2012) 1.63
Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63
Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol (2004) 1.63
Single-incision laparoscopic surgery: initial urological experience and comparison with natural-orifice transluminal endoscopic surgery. BJU Int (2008) 1.62
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study. J Urol (2011) 1.62
Laparoendoscopic single-site surgery in urology: where have we been and where are we heading? Nat Clin Pract Urol (2008) 1.62
Completely transvaginal NOTES cholecystectomy using magnetically anchored instruments. Surg Endosc (2007) 1.61
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer (2010) 1.58
Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int (2013) 1.58
Management of ureteral calculi: a cost comparison and decision making analysis. J Urol (2002) 1.57
Trocar-less instrumentation for laparoscopy: magnetic positioning of intra-abdominal camera and retractor. Ann Surg (2007) 1.57
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol (2005) 1.54
Minimally invasive nephrectomy: the influence of laparoendoscopic single-site surgery on patient selection, outcomes, and morbidity. Urology (2010) 1.54
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology (2008) 1.50
Urological laparoendoscopic single site surgery: multi-institutional analysis of risk factors for conversion and postoperative complications. J Urol (2012) 1.50
Consensus statement on natural orifice transluminal endoscopic surgery and single-incision laparoscopic surgery: heralding a new era in urology? Eur Urol (2008) 1.48
Training on a virtual reality laparoscopic simulator improves performance of an unfamiliar live laparoscopic procedure. J Urol (2008) 1.48
Laparoscopic radical nephrectomy: oncologic efficacy. Urol Clin North Am (2003) 1.47
Laparoscopic partial nephrectomy using holmium laser in a porcine model. JSLS (2004) 1.46
Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology (2007) 1.46
Robot-assisted laparoendoscopic single-site pyeloplasty: technique using the da Vinci Si robotic platform. J Endourol (2012) 1.45
Laparoendoscopic single-site nephrectomy compared with conventional laparoscopic nephrectomy: a 5-year, single-surgeon experience. Eur Urol (2013) 1.44
Importance of cosmesis to patients undergoing renal surgery: a comparison of laparoendoscopic single-site (LESS), laparoscopic and open surgery. BJU Int (2011) 1.43
Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol (2007) 1.42
Effect of testicular germ cell tumor therapy on renal function. Urology (2012) 1.41
Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol. Urology (2012) 1.40
Transvaginal laparoscopic nephrectomy: development and feasibility in the porcine model. Urology (2002) 1.40
Rendering stone fragments paramagnetic with iron-oxide microparticles improves the efficiency and effectiveness of endoscopic stone fragment retrieval. Urology (2010) 1.39
Is prolonged catheterization a risk factor for artificial urinary sphincter cuff erosion? Urology (2013) 1.39
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol (2006) 1.34
Surgical simulation: a urological perspective. J Urol (2008) 1.34
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol (2004) 1.31
Treatment of localised renal cell carcinoma. Eur Urol (2011) 1.29
Laparoscopic partial nephrectomy with a diode laser: porcine results. J Endourol (2002) 1.29
Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem (2010) 1.24
Natural history of residual fragments following percutaneous nephrostolithotomy. J Urol (2009) 1.24
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy. J Endourol (2005) 1.22
Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology (2003) 1.22
Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol (2012) 1.21
Contemporary management of small renal masses. Eur Urol (2011) 1.19
Single trocar laparoscopic nephrectomy using magnetic anchoring and guidance system in the porcine model. J Urol (2007) 1.18
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int (2007) 1.17
Role of magnetic anchors during laparoendoscopic single site surgery and NOTES. J Endourol (2009) 1.15
Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management. J Urol (2005) 1.14
Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol (2006) 1.12
Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol (2002) 1.12
Where do we really stand with LESS and NOTES? Eur Urol (2010) 1.11
The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons. BJU Int (2009) 1.10
Complications after percutaneous radiofrequency ablation of renal tumors. Urology (2005) 1.10
Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest (2012) 1.09
Transperitoneal laparoscopic pyelolithotomy after failed percutaneous access in the pediatric patient. J Urol (2004) 1.08
Re: A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. J Urol (2015) 1.06
International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res (2005) 1.06
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proc Natl Acad Sci U S A (2014) 1.04
Resorbable clip migration in the collecting system after laparoscopic partial nephrectomy. Urology (2006) 1.04
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol (2006) 1.03
Comparison of dismembered and nondismembered laparoscopic pyeloplasty in the pediatric patient. J Endourol (2004) 1.02
Significance of PELP1 in ER-negative breast cancer metastasis. Mol Cancer Res (2011) 1.02
Robotic percutaneous access to the kidney: comparison with standard manual access. J Endourol (2002) 1.01
Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J Endourol (2005) 1.01
Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol (2013) 1.00
Growing teratoma syndrome. Urology (2009) 1.00
Virtual ureteroscopy predicts ureteroscopic proficiency of medical students on a cadaver. J Urol (2004) 1.00
Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol (2012) 0.99
Active DLP hyperspectral illumination: a noninvasive, in vivo, system characterization visualizing tissue oxygenation at near video rates. Anal Chem (2011) 0.99
Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol (2004) 0.99
Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology (2005) 0.99
Clinical use of the holmium: YAG laser in laparoscopic partial nephrectomy. J Endourol (2002) 0.99
Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer. Mol Endocrinol (2012) 0.98
Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol (2007) 0.98
Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol (2002) 0.98
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. Nat Rev Urol (2011) 0.98